EMA fast-tracks new oral treatment for non-small cell lung cancer

View source ↗

Summary

EMA has fast-tracked an oral treatment for non-small cell lung cancer, indicating accelerated consideration for patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer